Skip to main content


You are here

The Daily Record: UMB Licences Potential Prostate Cancer Treatment to Startup

Tuesday, December 18, 2018

The University of Maryland, Baltimore has granted Educational & Scientific, LLC an exclusive license with the potential to treat prostate cancer, UM Ventures announced Monday. The agreement allows Educational & Scientific to develop Galeterone, a molecule that could inhibit prostate cancer growth in patients with castration-resistant prostate cancer...

Click here to read the rest of the story via The Daily Record.